Vivo Capital, LLC Obs Eva Sa Transaction History

Vivo Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$8.22 - $11.2 $7.7 Million - $10.5 Million	-937,147 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$10.92 - $18.18 $132,645 - $220,832	12,147 Added 1.31%	937,147 $16.9 Million
Q2 2018 Aug 10, 2018	BUY	$10.0 - $17.87 $9.25 Million - $16.5 Million	925,000 New	925,000 $14 Million

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.